DD143769A5 - Verfahren zur herstellung von substituierten hydantoinderivaten - Google Patents

Verfahren zur herstellung von substituierten hydantoinderivaten Download PDF

Info

Publication number
DD143769A5
DD143769A5 DD79213034A DD21303479A DD143769A5 DD 143769 A5 DD143769 A5 DD 143769A5 DD 79213034 A DD79213034 A DD 79213034A DD 21303479 A DD21303479 A DD 21303479A DD 143769 A5 DD143769 A5 DD 143769A5
Authority
DD
German Democratic Republic
Prior art keywords
butyl
hydantoin
compound
formula
phenyl
Prior art date
Application number
DD79213034A
Other languages
German (de)
English (en)
Inventor
William B Jamieson
William J Ross
Robin G Simmonds
John P Verge
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DD143769A5 publication Critical patent/DD143769A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD79213034A 1978-05-23 1979-05-21 Verfahren zur herstellung von substituierten hydantoinderivaten DD143769A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins

Publications (1)

Publication Number Publication Date
DD143769A5 true DD143769A5 (de) 1980-09-10

Family

ID=10161451

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79213034A DD143769A5 (de) 1978-05-23 1979-05-21 Verfahren zur herstellung von substituierten hydantoinderivaten

Country Status (31)

Country Link
US (2) US4241073A (pt)
EP (1) EP0005647B1 (pt)
JP (1) JPS54160373A (pt)
KR (1) KR830000635B1 (pt)
AR (2) AR225143A1 (pt)
AT (1) AT366034B (pt)
AU (1) AU530968B2 (pt)
BE (1) BE876435A (pt)
BG (2) BG31799A3 (pt)
CA (1) CA1120481A (pt)
CH (2) CH639650A5 (pt)
CS (2) CS208653B2 (pt)
DD (1) DD143769A5 (pt)
DE (1) DE2963061D1 (pt)
DK (1) DK207579A (pt)
ES (1) ES480850A1 (pt)
FI (1) FI791614A (pt)
FR (1) FR2426681A1 (pt)
GB (1) GB1601310A (pt)
GR (1) GR68363B (pt)
HU (1) HU184648B (pt)
IL (1) IL57343A (pt)
LU (1) LU81300A1 (pt)
MX (1) MX5604E (pt)
NZ (1) NZ190512A (pt)
PL (2) PL119612B1 (pt)
PT (1) PT69648A (pt)
RO (2) RO76807A (pt)
SU (2) SU873878A3 (pt)
YU (1) YU120179A (pt)
ZA (1) ZA792501B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT395852B (de) * 1987-01-31 1993-03-25 Sandoz Ag Imidazolyl-methyl-tetrahydrothiophenderivate

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
CA2080917C (en) * 1990-04-27 2001-06-12 Reijo Baeckstroem New pharmacologically active catechol derivatives
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
WO1995029910A1 (en) * 1994-04-28 1995-11-09 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
BR0214437A (pt) * 2001-11-30 2004-10-13 Lilly Co Eli Composto, composição farmacêutica, métodos de modular um receptor ativado por proliferador de peroxissoma, de tratar e de prevenir a diabete melito, e de tratar a sìndrome x, e doenças cardiovasculares em um mamìfero, e, uso de um composto
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
JP5167350B2 (ja) * 2007-05-30 2013-03-21 エフ．ホフマン−ラ ロシュ アーゲー 非ヌクレオシド系逆転写酵素阻害剤
EP2217573A4 (en) * 2007-11-01 2011-08-31 Uab Research Foundation TREATMENT AND PREVENTION OF VIRUS INFECTIONS
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
NL131665C (pt) * 1964-05-18
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
JPS5136332B1 (pt) * 1970-12-09 1976-10-07
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT395852B (de) * 1987-01-31 1993-03-25 Sandoz Ag Imidazolyl-methyl-tetrahydrothiophenderivate

Also Published As

Publication number Publication date
CS208653B2 (en) 1981-09-15
BG31799A3 (en) 1982-03-15
FR2426681B1 (pt) 1983-08-12
CH639650A5 (fr) 1983-11-30
SU988190A3 (ru) 1983-01-07
AR224186A1 (es) 1981-10-30
CS208654B2 (en) 1981-09-15
EP0005647A1 (en) 1979-11-28
AU4728979A (en) 1979-11-29
DE2963061D1 (en) 1982-07-29
RO79703A (ro) 1982-08-17
CA1120481A (en) 1982-03-23
GR68363B (pt) 1981-12-23
US4241073A (en) 1980-12-23
LU81300A1 (fr) 1980-12-16
PT69648A (en) 1979-06-01
KR830000635B1 (ko) 1983-03-23
IL57343A0 (en) 1979-09-30
AU530968B2 (en) 1983-08-04
BG32115A4 (en) 1982-05-14
CH643546A5 (fr) 1984-06-15
GB1601310A (en) 1981-10-28
PL125075B1 (en) 1983-03-31
RO76807A (ro) 1981-04-26
FI791614A (fi) 1979-11-24
SU873878A3 (ru) 1981-10-15
AR225143A1 (es) 1982-02-26
NZ190512A (en) 1984-10-19
BE876435A (fr) 1979-11-21
JPS54160373A (en) 1979-12-19
US4293563A (en) 1981-10-06
PL222701A1 (pt) 1980-12-15
AT366034B (de) 1982-03-10
YU120179A (en) 1983-02-28
HU184648B (en) 1984-09-28
ES480850A1 (es) 1980-02-01
ATA373379A (de) 1981-07-15
MX5604E (es) 1983-11-07
FR2426681A1 (fr) 1979-12-21
EP0005647B1 (en) 1982-06-09
ZA792501B (en) 1980-05-28
IL57343A (en) 1982-09-30
PL119612B1 (en) 1982-01-30
PL215773A1 (pt) 1980-07-14
DK207579A (da) 1979-11-24

Similar Documents

Publication Publication Date Title
DD143769A5 (de) Verfahren zur herstellung von substituierten hydantoinderivaten
EP0149242B1 (de) 1-(2-Hydroxyaryl)-alkan-1-on-oxime, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE3502392A1 (de) Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
EP0127726B1 (de) Hydroxamsäuren, ihre Herstellung und ihre Verwendung in pharmazeutischen Mitteln
EP0005545A2 (de) Neue Imidazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DD150002A5 (de) Verfahren zur herstellung einer pyranon-verbindung
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD251126A1 (de) Verfahren zur herstellung neuer 2-arylsulfonamido-benzo- und -acetophenone und deren oxime, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3041097A1 (de) Substituierte oxocarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
EP0014847A1 (de) Pyrazolderivate, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE4320801A1 (de) 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel
DE3873278T2 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69326111T2 (de) Hydantoinderivate, deren Salze und diese enthaltende Maillard-Reaktionsinhibitoren
DD150001A5 (de) Verfahren zur herstellung einer pyranon-verbindung
DE1793049B2 (de) Benzofuran 2 carbonsauren und deren Salze mit pharmakologisch vertraglichen anorganischen oder organischen Basen sowie Arzneimittel mit einem Gehalt die ser Verbindungen
DE4126543A1 (de) 3(5)-(hydroxyaryl)-pyrazole und ihre verwendung als wirkstoffe in arzneimittel
DE2241027A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
DE2950478A1 (de) 4,5-diaryl-4-imidazolin-2-on-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DD146046A5 (de) Verfahren zur herstellung von auronderivaten
DE2461039A1 (de) Arzneimittel
EP0091045B1 (de) 2-Pyrrolin-3-carbonitril-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3111522C2 (pt)
DE2537204A1 (de) Neue benzopyrane und verfahren zu ihrer herstellung
EP0276805A2 (de) Substituierte 3-Phenyl-7H-thiazolo[3,2 -b] [1,2,4]triazin-7-one, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel und ihre Verwendung, sowie einige bei der Herstellung der genannten Verbindungen gebildete Zwischenprodukte